Kewaunee Scientific Corporation
KEQU · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $90,640 | $102,780 | $44,069 | $39,728 |
| - Cash | $14,942 | $23,267 | $8,078 | $4,433 |
| + Debt | $50,155 | $11,002 | $12,923 | $67,565 |
| Enterprise Value | $125,853 | $90,515 | $48,914 | $102,860 |
| Revenue | $240,472 | $203,755 | $219,494 | $168,872 |
| % Growth | 18% | -7.2% | 30% | – |
| Gross Profit | $68,857 | $52,051 | $35,588 | $24,220 |
| % Margin | 28.6% | 25.5% | 16.2% | 14.3% |
| EBITDA | $22,758 | $18,043 | $8,160 | $916 |
| % Margin | 9.5% | 8.9% | 3.7% | 0.5% |
| Net Income | $11,405 | $18,753 | $1,359 | -$6,003 |
| % Margin | 4.7% | 9.2% | 0.6% | -3.6% |
| EPS Diluted | 3.83 | 6.38 | 0.47 | -2.15 |
| % Growth | -40% | 1,257.4% | 121.9% | – |
| Operating Cash Flow | $14,783 | $19,564 | -$3,790 | -$7,885 |
| Capital Expenditures | -$2,166 | -$4,373 | -$4,148 | -$1,908 |
| Free Cash Flow | $12,617 | $15,191 | -$7,938 | -$9,793 |